Tamara Brady, PA
Physician Assistant · Anaheim
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 4
- Since medical school
- 13 years
- Graduated 2013
Offices
4 locations · Providence Medical Foundation · 1,461 clinicians in this group
Hospitals listed: Providence Queen of the Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Tamara Brady’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence C51433 · Cancelled
Licence status: Cancelled · since 2003 · Tehran University of Medical Sciences and Health Services.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Queen of the Valley Medical CenterNapa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.107, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Queen of the Valley Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.107 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.92) · 609 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.5 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 191.43 (130.54 to 252.33) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 271 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.7 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 175 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.41) · 4,152 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,188 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (1.63 to 5.99) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.21) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.62 to 3.77) · 742 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.45 (0.91 to 16) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.58 (1.75 to 9.42) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 152 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.94) · 2,994 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.684 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.887 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 270 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.8 · 143 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.1 · 316 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -1 · 399 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.4 · 337 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.5 to 7.8) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (9.8 to 17.7) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.4 to 16.2) · 848 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 423 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$112,277
Medicare paid this office $112,277 for 233 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 156 | $43,704 | $93 |
| Insertion of lower leg neurostimulator electrode | 43 | $32,742 | $93 |
| Long return visit (40+ min) | 78 | $12,843 | $131 |
| Complicated change of bladder tube | 15 | $7,596 | $106 |
| New patient visit (45+ min) | 23 | $2,405 | $105 |
See all 10 services
| Return visit (30+ min) | 156 | $43,704 | $93 |
| Insertion of lower leg neurostimulator electrode | 43 | $32,742 | $93 |
| Long return visit (40+ min) | 78 | $12,843 | $131 |
| Complicated change of bladder tube | 15 | $7,596 | $106 |
| New patient visit (45+ min) | 23 | $2,405 | $105 |
| New patient visit (60+ min) | 12 | $1,684 | $140 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 110 | $1,528 | $12 |
| Ultrasound measurement of bladder capacity after voiding | 67 | $868 | $11 |
| Injection of drug or substance under skin or into muscle | 14 | $248 | $11 |
| Injection, garamycin, gentamicin, up to 80 mg | 32 | $188 | None |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Insertion of lower leg neurostimulator electrode | – | 91 | 288 | 363 | 353 |
| Ultrasound measurement of bladder capacity after voiding | 37 | 41 | 37 | 36 | 77 |
| Complicated change of bladder tube | – | – | – | 45 | 72 |
| Simple bladder irrigation and/or instillation | 18 | 19 | 31 | 28 | – |
| Complicated insertion of bladder tube | – | – | – | 23 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
233 Original Medicare patients in 2024. Average age 77 · Women 54% · Also on Medicaid 25% · Health risk score 1.45. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Chronic kidney disease 31% · Coronary heart disease 28% · Diabetes 27% · Cancer 25% · Atrial fibrillation 25% · Depression 24% · Heart failure 20% · COPD 14% · Stroke 12% · Dementia 7%.
The office billed $523,897, Medicare allowed $148,522 and paid $112,277; for 2,358 services of 27 kinds; $2,897 of it was for drugs given in the office and $109,380 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 233 | 2,358 | 77 | 1.45 | $523,897 | $112,277 |
| 2023 | 248 | 4,725 | 78 | 1.49 | $380,289 | $103,378 |
| 2022 | 237 | 8,858 | 77 | 1.53 | $341,170 | $99,638 |
| 2021 | 190 | 1,578 | 76 | 1.57 | $137,113 | $51,716 |
| 2020 | 169 | 446 | 75 | 1.52 | $84,123 | $26,923 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 165 | $37,255 | $91 |
| Insertion of lower leg neurostimulator electrode | 49 | $34,140 | $94 |
| Long return visit (40+ min) | 36 | $5,327 | $124 |
| Complicated change of bladder tube | 12 | $4,533 | $101 |
| New patient visit (45+ min) | 35 | $3,680 | $105 |
| Complicated insertion of bladder tube | 13 | $2,486 | $108 |
| New patient visit (60+ min) | 15 | $2,297 | $153 |
| Simple bladder irrigation and/or instillation | 25 | $1,640 | $59 |
| Short return visit (20+ min) | 23 | $1,372 | $55 |
| Injection of drug or substance under skin or into muscle | 34 | $837 | $11 |
| Ultrasound measurement of bladder capacity after voiding | 34 | $369 | $10 |
| Injection, garamycin, gentamicin, up to 80 mg | 44 | $206 | None |
2022: 9 services
| Return visit (30+ min) | 152 | $31,140 | $94 |
| Insertion of lower leg neurostimulator electrode | 33 | $28,374 | $99 |
| Short return visit (20+ min) | 58 | $8,151 | $67 |
| New patient visit (45+ min) | 30 | $3,619 | $121 |
| Simple bladder irrigation and/or instillation | 26 | $1,920 | $62 |
| Long return visit (40+ min) | 13 | $1,914 | $137 |
| Injection of drug or substance under skin or into muscle | 39 | $934 | $11 |
| Ultrasound measurement of bladder capacity after voiding | 33 | $370 | $10 |
| Injection, garamycin, gentamicin, up to 80 mg | 51 | $190 | None |
2021: 8 services
| Return visit (30+ min) | 131 | $19,844 | $91 |
| Insertion of lower leg neurostimulator electrode | 12 | $9,485 | $104 |
| Short return visit (20+ min) | 50 | $5,984 | $67 |
| New patient visit (45+ min) | 36 | $3,726 | $103 |
| Simple bladder irrigation and/or instillation | 19 | $1,199 | $63 |
| Injection of drug or substance under skin or into muscle | 46 | $1,154 | $11 |
| Ultrasound measurement of bladder capacity after voiding | 36 | $411 | $10 |
| Injection, garamycin, gentamicin, up to 80 mg | 45 | $150 | None |
2020: 8 services
| Short return visit (20+ min) | 68 | $5,575 | $57 |
| Return visit (30+ min) | 46 | $5,041 | $84 |
| New patient visit (45+ min) | 28 | $3,346 | $120 |
| New patient visit (30+ min) | 36 | $2,742 | $76 |
| Simple bladder irrigation and/or instillation | 11 | $727 | $40 |
| Injection of drug or substance under skin or into muscle | 25 | $447 | $11 |
| Ultrasound measurement of bladder capacity after voiding | 30 | $375 | $10 |
| Injection, garamycin, gentamicin, up to 80 mg | 25 | $64 | None |
Medicaid work
$36,372 in 2018
Medicaid paid $36,372 for 1,466 billed services this clinician did in 2018, up to 153 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 270 | $32,084 |
| Short return visit (20+ min) | 1,056 | $3,583 |
| New patient visit (30+ min) | 14 | $426 |
| Return visit (30+ min) | 64 | $279 |
| EMERGENCY DEPT VISIT LOW MDM | 62 | $0 |
| 2018 | 1,466 | 5 | 153 | $36,372 |
Drugs they prescribed that Part D paid
$151,806
Pharmacies billed $151,806 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
643 generic and fewer than 11 brand-name prescriptions · $151,806 in drug cost · 70 antibiotic prescriptions to 65 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 62 | $73,636 | $1,188 |
| Gemtesa | 31 | $35,444 | $1,143 |
| Premarin | 21 | $9,126 | $435 |
| Estradiol | 114 | $7,168 | $63 |
| Potassium Citrate Er | 33 | $6,138 | $186 |
See all 16 drugs
| Myrbetriq | 62 | $73,636 | $1,188 |
| Gemtesa | 31 | $35,444 | $1,143 |
| Premarin | 21 | $9,126 | $435 |
| Estradiol | 114 | $7,168 | $63 |
| Potassium Citrate Er | 33 | $6,138 | $186 |
| Tamsulosin | 197 | $3,646 | $19 |
| Solifenacin | 31 | $2,082 | $67 |
| Trospium Chloride | 17 | $1,283 | $75 |
| Finasteride | 90 | $1,128 | $13 |
| Oxybutynin Chloride Er | 34 | $1,024 | $30 |
| Oxybutynin Chloride | 12 | $468 | $39 |
| Fesoterodine Fumarate Er | 11 | $265 | $24 |
| Nitrofurantoin Mono-Macro | 19 | $235 | $12 |
| Sulfamethoxazole-Trimethoprim | 17 | $48 | $3 |
| Ciprofloxacin | 11 | $40 | $4 |
| Anastrozole | 14 | $33 | $2 |
Year by year
| 2024 | 771 | 299 | None | None | $151,806 |
| 2023 | 824 | 275 | None | None | $180,578 |
| 2022 | 683 | 231 | None | 20% | $139,064 |
| 2021 | 408 | 171 | 0% (0) | 18% | $65,506 |
| 2020 | 947 | 206 | None | 17% | $93,281 |
| 2019 | 1,969 | 218 | 1% (24) | 21% | $197,381 |
| 2018 | 1,762 | 191 | 2% (31) | 19% | $190,647 |
| 2017 | 1,509 | 251 | 2% (25) | 17% | $101,481 |
| 2016 | 1,117 | 211 | 4% (43) | 15% | $44,507 |
| 2015 | 483 | 184 | 6% (31) | None | $18,677 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Myrbetriq | 92 | $100,702 | $1,095 |
| Premarin | 30 | $15,703 | $523 |
| Estradiol | 73 | $8,426 | $115 |
| Tamsulosin | 231 | $7,589 | $33 |
| Potassium Citrate Er | 27 | $7,372 | $273 |
| Solifenacin | 39 | $7,089 | $182 |
| Oxybutynin Chloride Er | 34 | $2,113 | $62 |
| Finasteride | 72 | $1,777 | $25 |
| Oxybutynin Chloride | 27 | $1,214 | $45 |
| Trospium Chloride | 11 | $1,171 | $106 |
| Nitrofurantoin Mono-Macro | 43 | $707 | $16 |
| Bicalutamide | 14 | $474 | $34 |
| Cephalexin | 13 | $172 | $13 |
| Sulfamethoxazole-Trimethoprim | 22 | $101 | $5 |
2022: 14 drugs
| Myrbetriq | 80 | $73,888 | $924 |
| Premarin | 26 | $12,558 | $483 |
| Toviaz | 11 | $8,464 | $769 |
| Potassium Citrate Er | 26 | $6,678 | $257 |
| Solifenacin | 38 | $5,827 | $153 |
| Estradiol | 48 | $5,756 | $120 |
| Tamsulosin | 181 | $4,564 | $25 |
| Oxybutynin Chloride Er | 46 | $3,057 | $66 |
| Oxybutynin Chloride | 45 | $1,844 | $41 |
| Finasteride | 38 | $891 | $23 |
| Bicalutamide | 20 | $606 | $30 |
| Cephalexin | 27 | $518 | $19 |
| Nitrofurantoin Mono-Macro | 18 | $363 | $20 |
| Sulfamethoxazole-Trimethoprim | 11 | $46 | $4 |
2021: 12 drugs
| Myrbetriq | 28 | $24,323 | $869 |
| Premarin | 13 | $9,367 | $721 |
| Toviaz | 11 | $7,171 | $652 |
| Estradiol | 29 | $4,048 | $140 |
| Potassium Citrate Er | 11 | $3,162 | $287 |
| Tamsulosin | 91 | $2,806 | $31 |
| Oxybutynin Chloride Er | 27 | $1,694 | $63 |
| Oxybutynin Chloride | 24 | $1,004 | $42 |
| Cephalexin | 22 | $367 | $17 |
| Nitrofurantoin Mono-Macro | 27 | $358 | $13 |
| Finasteride | 14 | $263 | $19 |
| Sulfamethoxazole-Trimethoprim | 17 | $119 | $7 |
2020: 23 drugs
| Myrbetriq | 15 | $9,290 | $619 |
| Flovent Hfa | 11 | $3,310 | $301 |
| Nifedipine Er | 12 | $857 | $71 |
| Atorvastatin | 56 | $691 | $12 |
| Albuterol Sulfate Hfa | 14 | $668 | $48 |
| Levothyroxine | 25 | $636 | $25 |
| Tamsulosin | 30 | $547 | $18 |
| Oxybutynin Chloride | 20 | $537 | $27 |
| Fluticasone Propionate | 19 | $402 | $21 |
| Omeprazole | 20 | $377 | $19 |
| Metformin | 52 | $343 | $7 |
| Montelukast | 14 | $301 | $21 |
| Gabapentin | 23 | $293 | $13 |
| Nitrofurantoin Mono-Macro | 16 | $259 | $16 |
| Lisinopril | 50 | $218 | $4 |
| Losartan | 21 | $181 | $9 |
| Amlodipine Besylate | 31 | $175 | $6 |
| Fluoxetine | 11 | $159 | $14 |
| Ibuprofen | 11 | $158 | $14 |
| Simvastatin | 20 | $146 | $7 |
| Pravastatin | 11 | $125 | $11 |
| Trazodone | 13 | $117 | $9 |
| Hydrochlorothiazide | 16 | $76 | $5 |
2019: 45 drugs
| Januvia | 19 | $22,775 | $1,199 |
| Advair Diskus | 23 | $13,512 | $587 |
| Levemir | 13 | $8,734 | $672 |
| Tradjenta | 12 | $8,732 | $728 |
| Combivent Respimat | 12 | $8,132 | $678 |
| Flovent Hfa | 27 | $6,983 | $259 |
| Chantix | 15 | $6,665 | $444 |
| Ventolin Hfa | 52 | $3,228 | $62 |
| Atorvastatin | 123 | $1,719 | $14 |
| Gabapentin | 41 | $1,552 | $38 |
| Levothyroxine | 58 | $1,414 | $24 |
| Albuterol Sulfate Hfa | 24 | $1,173 | $49 |
| Fluticasone Propionate | 60 | $914 | $15 |
| Metformin | 135 | $887 | $7 |
| Lisinopril | 142 | $874 | $6 |
| Bupropion Xl | 15 | $643 | $43 |
| Ranitidine | 21 | $635 | $30 |
| Omeprazole | 42 | $554 | $13 |
| Tamsulosin | 22 | $438 | $20 |
| Metoprolol | 13 | $432 | $33 |
| Amlodipine Besylate | 79 | $400 | $5 |
| Nitrofurantoin Mono-Macro | 14 | $362 | $26 |
| Trazodone | 24 | $362 | $15 |
| Losartan | 38 | $330 | $9 |
| Pioglitazone | 17 | $300 | $18 |
| Montelukast | 18 | $299 | $17 |
| Simvastatin | 35 | $270 | $8 |
| Alendronate | 16 | $236 | $15 |
| Hydrochlorothiazide | 45 | $230 | $5 |
| Methadone | 21 | $225 | $11 |
| Fluoxetine | 32 | $222 | $7 |
| Lisinopril-Hydrochlorothiazide | 16 | $216 | $13 |
| Irbesartan | 13 | $198 | $15 |
| Paroxetine | 20 | $187 | $9 |
| Clotrimazole | 11 | $179 | $16 |
| Naproxen | 19 | $166 | $9 |
| Pravastatin | 15 | $155 | $10 |
| Glipizide | 17 | $150 | $9 |
| Ibuprofen | 17 | $150 | $9 |
| Triamcinolone Acetonide | 13 | $141 | $11 |
| Furosemide | 25 | $137 | $5 |
| Sertraline | 14 | $137 | $10 |
| Metoprolol | 21 | $88 | $4 |
| Warfarin | 17 | $78 | $5 |
| Fluconazole | 11 | $48 | $4 |
2018: 44 drugs
| Januvia | 13 | $16,962 | $1,305 |
| Advair Diskus | 14 | $9,681 | $691 |
| Lantus | 18 | $8,927 | $496 |
| Levemir | 13 | $8,559 | $658 |
| Tradjenta | 11 | $7,985 | $726 |
| Flovent Hfa | 24 | $7,759 | $323 |
| Combivent Respimat | 11 | $6,416 | $583 |
| Ventolin Hfa | 52 | $3,657 | $70 |
| Celecoxib | 12 | $2,492 | $208 |
| Atorvastatin | 87 | $1,506 | $17 |
| Gabapentin | 42 | $1,416 | $34 |
| Levothyroxine | 56 | $1,307 | $23 |
| Nifedipine Er | 12 | $1,154 | $96 |
| Metformin | 132 | $776 | $6 |
| Lisinopril | 132 | $729 | $6 |
| Omeprazole | 45 | $556 | $12 |
| Amlodipine Besylate | 75 | $516 | $7 |
| Tamsulosin | 29 | $514 | $18 |
| Losartan | 53 | $472 | $9 |
| Venlafaxine Hcl Er | 15 | $434 | $29 |
| Bupropion Xl | 15 | $384 | $26 |
| Ranitidine | 19 | $356 | $19 |
| Fluticasone Propionate | 34 | $343 | $10 |
| Hydrochlorothiazide | 44 | $317 | $7 |
| Methadone | 21 | $281 | $13 |
| Mirtazapine | 11 | $277 | $25 |
| Montelukast | 14 | $252 | $18 |
| Pravastatin | 13 | $219 | $17 |
| Sertraline | 25 | $193 | $8 |
| Simvastatin | 44 | $177 | $4 |
| Lisinopril-Hydrochlorothiazide | 24 | $168 | $7 |
| Glipizide | 22 | $158 | $7 |
| Warfarin | 12 | $152 | $13 |
| Naproxen | 15 | $149 | $10 |
| Triamcinolone Acetonide | 23 | $143 | $6 |
| Fluoxetine | 16 | $120 | $8 |
| Metoprolol | 24 | $109 | $5 |
| Carvedilol | 14 | $98 | $7 |
| Citalopram Hbr | 17 | $98 | $6 |
| Ibuprofen | 13 | $92 | $7 |
| Alendronate | 17 | $81 | $5 |
| Ibu | 11 | $64 | $6 |
| Trazodone | 11 | $62 | $6 |
| Furosemide | 17 | $62 | $4 |
2017: 37 drugs
| Advair Diskus | 24 | $18,165 | $757 |
| Flovent Hfa | 29 | $7,509 | $259 |
| Ventolin Hfa | 37 | $2,612 | $71 |
| Venlafaxine Hcl Er | 13 | $1,818 | $140 |
| Proair Hfa | 18 | $1,138 | $63 |
| Zolmitriptan | 12 | $1,058 | $88 |
| Levothyroxine | 38 | $932 | $25 |
| Gabapentin | 35 | $914 | $26 |
| Lisinopril | 118 | $807 | $7 |
| Omeprazole | 80 | $775 | $10 |
| Atorvastatin | 45 | $691 | $15 |
| Metformin | 93 | $677 | $7 |
| Losartan | 43 | $501 | $12 |
| Fluticasone Propionate | 40 | $498 | $12 |
| Tamsulosin | 24 | $426 | $18 |
| Synthroid | 12 | $412 | $34 |
| Metoprolol | 16 | $411 | $26 |
| Simvastatin | 60 | $407 | $7 |
| Amlodipine Besylate | 51 | $377 | $7 |
| Warfarin | 33 | $321 | $10 |
| Diltiazem 24hr Er | 20 | $311 | $16 |
| Glipizide | 32 | $277 | $9 |
| Ibu | 18 | $167 | $9 |
| Diltiazem Er | 11 | $165 | $15 |
| Hydrochlorothiazide | 35 | $154 | $4 |
| Hydrocodone-Acetaminophen | 14 | $154 | $11 |
| Fluoxetine | 14 | $140 | $10 |
| Clopidogrel | 17 | $134 | $8 |
| Furosemide | 24 | $132 | $5 |
| Metoprolol | 18 | $99 | $5 |
| Alendronate | 14 | $91 | $6 |
| Gemfibrozil | 12 | $90 | $7 |
| Sertraline | 11 | $87 | $8 |
| Trazodone | 12 | $85 | $7 |
| Citalopram Hbr | 13 | $69 | $5 |
| Lisinopril-Hydrochlorothiazide | 14 | $56 | $4 |
| Irbesartan | 12 | $47 | $4 |
2016: 29 drugs
| Symbicort | 12 | $3,295 | $275 |
| Flovent Hfa | 13 | $2,763 | $213 |
| Proair Hfa | 23 | $1,407 | $61 |
| Hydrocodone-Acetaminophen | 40 | $1,101 | $28 |
| Levothyroxine | 43 | $911 | $21 |
| Omeprazole | 67 | $872 | $13 |
| Atorvastatin | 35 | $811 | $23 |
| Gabapentin | 38 | $598 | $16 |
| Lisinopril | 67 | $559 | $8 |
| Tamsulosin | 28 | $556 | $20 |
| Metformin | 62 | $550 | $9 |
| Nifedipine Er | 18 | $453 | $25 |
| Losartan | 41 | $450 | $11 |
| Bupropion Hcl Sr | 15 | $409 | $27 |
| Metoprolol | 17 | $353 | $21 |
| Simvastatin | 51 | $345 | $7 |
| Phenytoin Sodium Extended | 12 | $290 | $24 |
| Potassium Chloride | 11 | $265 | $24 |
| Gemfibrozil | 14 | $250 | $18 |
| Fluticasone Propionate | 30 | $224 | $7 |
| Estradiol | 16 | $199 | $12 |
| Sertraline | 14 | $182 | $13 |
| Warfarin | 16 | $172 | $11 |
| Azithromycin | 21 | $159 | $8 |
| Ramipril | 16 | $138 | $9 |
| Hydrochlorothiazide | 23 | $106 | $5 |
| Citalopram Hbr | 26 | $102 | $4 |
| Furosemide | 23 | $81 | $4 |
| Prednisone | 12 | $45 | $4 |
2015: 15 drugs
| Proair Hfa | 23 | $1,169 | $51 |
| Hydrocodone-Acetaminophen | 24 | $560 | $23 |
| Levothyroxine | 19 | $456 | $24 |
| Gabapentin | 13 | $345 | $27 |
| Omeprazole | 22 | $216 | $10 |
| Azithromycin | 24 | $206 | $9 |
| Losartan | 17 | $153 | $9 |
| Fluticasone Propionate | 12 | $123 | $10 |
| Lisinopril | 23 | $104 | $5 |
| Simvastatin | 11 | $90 | $8 |
| Metformin | 13 | $72 | $6 |
| Cephalexin | 13 | $70 | $5 |
| Prednisone | 11 | $45 | $4 |
| Hydrochlorothiazide | 12 | $31 | $3 |
| Furosemide | 12 | $25 | $2 |
Money from drug and device companies
$136 in 2025
| 2025 | 4 | 5 | None | $136 |
| 2024 | 4 | 5 | None | $99 |
| 2023 | 9 | 14 | None | $700 |
| 2022 | 4 | 5 | None | $171 |
| 2021 | 2 | 2 | None | $76 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Erleada | $57 | 2 payments
|
| Davol | Arista | $30 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $26 | 1 payment
|
| Abbvie | Botox | $23 | 1 payment
|
See all 5 published payments
| Janssen Biotech | Meals · 2025-05-22 | Erleada | $30 |
| Davol | Meals · 2025-05-08 | Arista | $30 |
| Progenics Pharmaceuticals | Meals · 2025-04-23 | Pylarify | $26 |
| Abbvie | Meals · 2025-03-19 | Botox | $23 |
| Janssen Biotech | Meals · 2025-02-28 | Erleada | $27 |
See earlier years (2024, 2023, 2022, 2021)
2024: $99
| Telix Pharmaceuticals | Illuccix | $38 | 2 payments
|
| Progenics Pharmaceuticals | Pylarify | $30 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $18 | 1 payment
|
| Abbvie | Botox | $13 | 1 payment
|
2023: $700
| Intuitive Surgical | Da Vinci Surgical System | $456 | 4 payments
|
| Boston Scientific | Solyx Sis System | $57 | 2 payments
|
| Telix Pharmaceuticals | Illuccix | $46 | 2 payments
|
| Janssen Biotech | Erleada | $28 | 1 payment
|
| Abbvie | Botox | $26 | 1 payment
|
| Myriad Genetic Laboratories | Prolaris | $25 | 1 payment
|
| Koelis | Trinity | $24 | 1 payment
|
| Coloplast | Altis | $20 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $18 | 1 payment
|
2022: $171
| UroGen Pharma | Jelmyto | $72 | 1 payment
|
| Boston Scientific | General - Erectile Dysfunction | $48 | 2 payments
|
| Abbvie | Lupron Depot | $27 | 1 payment
|
| 180 Medical | Gentlecath | $24 | 1 payment
|
2021: $76
| Astellas Pharma US | Xtandi | $60 | 1 payment
|
| Alnylam Pharmaceuticals | Oxlumo | $16 | 1 payment
|
Professional record
- NPI
- 1427474949
- Licence
- CA 51433California C51433: Cancelled
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant, medical (363AM0700X)
- Mailing address
- 1141 Pear Tree Ln Ste 100, Napa, CA, 94558
- NPI first listed
- 2014-03-07
- NPI last updated
- 2021-03-29
- NPI record certified
- 2021-03-29
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.